8-K: American Healthcare REIT Launches $1.75B ATM Equity Offering

Sentiment:

Equity Offering Agreement


American Healthcare REIT, Inc. has entered into a new At-The-Market (ATM) equity offering sales agreement to sell up to $1.75 billion in common stock, replacing a prior program with $230 million remaining.

Capital raiseAmerican Healthcare REIT, Inc. entered into an ATM Equity Offering Sales Agreement to offer and sell shares of common stock with an aggregate gross sales price of up to $1.75 billion.The company terminated its prior ATM program, under which $230,139,575 remained unsold.Sales may occur through agents as sales agents or forward sellers, or directly to agents as principals.Commissions for agents will not exceed 2.0% of the gross sales price.The company may enter into forward sale agreements with Forward Purchasers, who will borrow and sell shares to hedge their exposure, with the company physically settling later.Net proceeds are intended for general corporate purposes, including debt repayment, working capital, capital expenditures, and potential future investments.

Summary

  • American Healthcare REIT, Inc. and its Operating Partnership entered into a new ATM Equity Offering Sales Agreement on February 27, 2026.
  • The agreement allows for the offer and sale of common stock with an aggregate gross sales price of up to $1.75 billion.
  • This new agreement replaces a prior ATM program, dated August 8, 2025, under which $230,139,575 remained unsold at the time of termination.
  • Shares may be sold through a syndicate of agents (BofA Securities, Barclays, Citigroup, Citizens JMP, Credit Agricole, Fifth Third, KeyBanc, Morgan Stanley, RBC, Regions, Truist) as sales agents, forward sellers, or directly to them as principals.
  • Sales can occur in negotiated transactions, including block trades, or as at-the-market offerings at prevailing market prices.
  • Agents will receive a commission not exceeding 2.0% of the gross sales price of shares sold through them.
  • The company may also enter into separate forward sale agreements with Forward Purchasers, who will borrow and sell shares to hedge their exposure, with the company physically settling these agreements later.
  • Net proceeds from the offering and any forward sale agreements will be contributed to the Operating Partnership in exchange for limited partnership units.
  • The Operating Partnership expects to use these net proceeds for general corporate purposes, including repaying or repurchasing indebtedness, working capital, capital expenditures, and potential future investments.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, providing substantial financial flexibility and access to capital for strategic initiatives, though it introduces potential for future share dilution.

Positives

  • Secures access to a substantial amount of capital (up to $1.75 billion) for general corporate purposes, including debt management and future investments.
  • Provides flexibility in raising capital over time, allowing the company to react to market conditions and specific funding needs.
  • The ability to use forward sale agreements offers additional financing options and potentially reduces immediate market impact from direct share sales.

Negatives

  • The offering introduces potential for significant shareholder dilution as new common stock shares are issued.
  • A large 'at-the-market' program can create an overhang on the stock, potentially impacting its trading price.
  • The termination of the prior ATM program with $230,139,575 unsold suggests that market conditions or company strategy may have limited its utilization.

Risks

  • Actual offers and sales of shares will depend on market conditions, the trading price of the common stock, and the company's capital needs, which may not always be favorable.
  • The company's ability to raise the full $1.75 billion is not guaranteed and is subject to market demand and pricing.
  • In connection with forward sale agreements, Forward Purchasers may be unable to borrow or deliver shares for sale, or may incur high stock loan costs, potentially impacting the effectiveness of this financing method.
  • Compliance with various securities regulations (e.g., Rule 10b-18, Regulation M) is required for sales and hedging activities, and any non-compliance could lead to adverse effects.
  • The forward price in forward sale agreements is subject to daily adjustment based on floating interest rates and quarterly dividends, which could affect the final proceeds received by the company.

Future Outlook

The company intends to use the net proceeds from the offering for general corporate purposes, which may include repaying or repurchasing indebtedness, funding working capital and capital expenditures, and making potential future investments. This indicates a focus on strengthening the balance sheet and supporting strategic growth initiatives.

Industry Context

StockSavvy.ai notes that REITs frequently utilize At-The-Market (ATM) offerings as a flexible and cost-effective method to access capital. This strategy allows American Healthcare REIT to opportunistically raise funds based on market conditions, which is a common practice in the real estate sector to finance acquisitions, development projects, or manage debt. The significant size of this offering suggests a proactive approach to capital management in the dynamic healthcare real estate market.

Comparison to Industry Standards

  • ATM offerings are a standard and widely adopted financing tool for publicly traded REITs, including those in the healthcare sector, due to their flexibility and lower issuance costs compared to traditional underwritten offerings.
  • The maximum aggregate gross sales price of $1.75 billion is a substantial amount, indicating American Healthcare REIT's significant capital needs or strategic growth ambitions, comparable to large-cap REITs like Prologis (PLD) or Simon Property Group (SPG) which also maintain large ATM programs for ongoing capital management.
  • The commission rate of up to 2.0% for agents is within the typical range observed for ATM programs in the industry, which generally fall between 1% and 3%.

Stakeholder Impact

  • **Shareholders:** Potential for dilution due to new share issuance, but also potential for increased company value through strategic use of capital for growth or debt reduction.
  • **Creditors:** Potential for improved credit profile and reduced leverage if proceeds are primarily used for debt repayment or strengthening the balance sheet.
  • **Employees, Customers, Suppliers:** Indirect positive impact from a more financially stable company with enhanced resources for operations, growth, and long-term strategic initiatives.

Next Steps

  • Offer and sell shares of common stock from time to time, depending on market conditions, trading price, and capital needs.
  • Potentially enter into separate forward sale agreements with Forward Purchasers.
  • Contribute net proceeds to the Operating Partnership in exchange for limited partnership units.
  • Use net proceeds for general corporate purposes, including debt repayment, working capital, capital expenditures, and future investments.

Key Dates

DateDescription
2024-08-12Date of filing of the shelf registration statement on Form S-3 (Registration No. 333-281488) with the SEC.
2025-08-08Date of the prior ATM Equity Offering Sales Agreement, which was terminated upon entry into the new agreement.
2026-02-27Date of entry into the new ATM Equity Offering Sales Agreement and filing of the prospectus supplement.

Keywords

American Healthcare REIT, AHR, ATM Offering, Equity Offering, Capital Raise, Common Stock, SEC Filing, REIT, Healthcare Real Estate, Dilution, Forward Sale Agreement, NYSE

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.